ECDS to Invest INR 780 Cr in Ujjain MedTech Manufacturing Facility

ECDS has outlined plans for an additional INR 1,250 Cr infusion within three years of starting MedTech production, using nanofiber technology and biomass polymer technology.

ECDS, a Delhi-based sustainable development technology firm, has committed INR 780 Cr to set up its first MedTech manufacturing unit in India, with construction scheduled to begin this year and commercial production targeted for April 2027.

The project has been planned at the Medical Equipment Park in Vikram Udyogpuri, Ujjain, positioning the company within a dedicated MedTech cluster designed to strengthen domestic medical device production.

The proposed facility will span 15.60 acres, of which 1.5 acres have already been acquired. According to Rajesh Bharadwaj, director of ECDS’s Indian branch, the company has formally submitted its proposal to the state government and intends to move ahead with construction within the year.

“We have submitted a proposal to the state government to set up a unit on 15.60 acres of land in the Medical Equipment Park in Vikram Udyogpuri, Ujjain, of which we have already acquired 1.5 acres. This will be our first unit in the country,” he said.

The initial phase of the MedTech project is expected to generate employment for approximately 500 people. “In the first phase, efforts will be made to provide employment to approximately 500 people,” Bharadwaj told reporters in Indore.

The company has partnered with three South Korean companies in a 50:50 joint venture to implement the project, combining international technology expertise with domestic manufacturing capacity.

Beyond the initial INR 780 Cr investment, ECDS has outlined plans for an additional INR 1,250 Cr infusion within three years of starting production, reflecting a long-term commitment to scaling its MedTech manufacturing footprint in India.

The unit will produce diagnostic kits for conditions such as cancer, kidney disease, and diabetes. These devices will be developed using nanofiber technology and biomass polymer technology, areas that are increasingly gaining relevance in next-generation MedTech innovation for precision diagnostics and sustainable medical materials.

Stay tuned for more such updates on Digital Health News